Aura Biosciences Inc (AURA) — Cash Flow-to-Debt Ratio
Latest as of March 2026:
-0.98x
Aura Biosciences Inc (AURA) has a Cash Flow-to-Debt Ratio of -0.98x as of March 2026, meaning its operating cash flow of $-29.89 Million could theoretically repay -1% of its total liabilities ($30.43 Million) in one year. See AURA financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.98x
Operating CF / Total Liabilities
Operating Cash Flow
$-29.89 Million
USD
Total Liabilities
$30.43 Million
USD
Data as of
Mar 2026
Most recent filing
Aura Biosciences Inc Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Aura Biosciences Inc across 7 annual periods. For the full cash flow conversion analysis, see Aura Biosciences Inc cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Aura Biosciences Inc (2019–2025)
Year-by-year debt coverage analysis for Aura Biosciences Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.61x | $-84.74 Million | $32.52 Million | ▲ +0.3% |
| 2024 | -2.61x | $-79.81 Million | $30.53 Million | ▼ -19.6% |
| 2023 | -2.18x | $-63.85 Million | $29.23 Million | ▼ -13.4% |
| 2022 | -1.93x | $-54.60 Million | $28.35 Million | ▲ +54.2% |
| 2021 | -4.20x | $-32.41 Million | $7.71 Million | ▲ +52.7% |
| 2020 | -8.87x | $-24.32 Million | $2.74 Million | ▼ -170.1% |
| 2019 | -3.28x | $-20.67 Million | $6.29 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.